Jeffrey Lawrence Schwartz's Net Worth

$514 Million

Estimate Recalculated Feb 22, 2024 04:09PM EST

Who is Jeffrey Lawrence Schwartz?

Jeffrey Lawrence Schwartz has an estimated net worth of $514 Million. This is based on reported shares across multiple companies, which include Dicerna Pharmaceuticals Inc, MARINUS PHARMACEUTICALS INC, RAPID MICRO BIOSYSTEMS, INC., Arcutis Biotherapeutics, Inc., Replimune Group, Inc., Annexon, Inc., Aptinyx Inc., BCLS Acquisition Corp., and SpringWorks Therapeutics, Inc..

SEC CIK

Jeffrey Lawrence Schwartz's CIK is 0001702957

Past Insider Trading and Trends

2020 was Jeffrey Lawrence Schwartz's most active year for acquiring shares with 9 total transactions. Jeffrey Lawrence Schwartz's most active month to acquire stocks was the month of April. 2017 was Jeffrey Lawrence Schwartz's most active year for disposing of shares, totalling 6 transactions. Jeffrey Lawrence Schwartz's most active month to dispose stocks was the month of November. 2020 saw Jeffrey Lawrence Schwartz paying a total of $26,674,988.00 for 11,049,217 shares, this is the most they've acquired in one year. In 2021 Jeffrey Lawrence Schwartz cashed out on 44,122,820 shares for a total of $173,925,000.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Dicerna Pharmaceuticals Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-23.87%
-1.75M
$22.03
-$38,552,500.00
5.58M
Nov 19
Form 4
-17.92%
-1.60M
$12.50
-$20,000,000.00
7.33M
May 29
Form 4
8.93M
$7.00
8.93M
Dec 18
Form 3
0
0
No matching records found

MARINUS PHARMACEUTICALS INC (MRNS) Snapshot price: $10

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-24.24%
-1.27M
$7.88
-$10,024,800.93
3.98M
Dec 15 - Dec 19
Form 3
0
0
No matching records found

RAPID MICRO BIOSYSTEMS, INC. (RPID) Snapshot price: $0.935

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
May 4
Form 4
0
0
May 23
Form 4
8.43M
$20.00
8.43M
Jul 19
Form 4
0
0
Jul 14
Form 3
0
0
No matching records found

Arcutis Biotherapeutics, Inc. (ARQT) Snapshot price: $5.725

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
3.98M
$17.00
3.98M
Feb 4
Form 3
0
0
No matching records found

SpringWorks Therapeutics, Inc. (SWTX) Snapshot price: $49.07

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+78.46%
4.65K
10.57K
May 24
Form 4
-36.22%
-1.75M
$28.50
-$49,875,000.00
3.08M
Mar 16
Form 4
+435.62%
4.82K
5.92K
May 19
Form 4
-17.15%
-1.00M
$70.25
-$70,250,000.00
4.83M
Aug 10
Form 4
1.11K
1.11K
May 20
Form 4
-19.91%
-1.45M
$71.50
-$103,675,000.00
5.83M
Mar 9
Form 4
0
0
May 20
Form 4
7.28M
$18.00
7.28M
Sep 17
Form 4
0
0
Mar 29 - Sep 12
Form 3
0
0
No matching records found